Kenyan manufactured drug recalled in Rwanda over irregularities
Several batches of Kenyan-manufactured drug, Fluconazole 200 mg tablets have been recalled by Rwanda’s Food and Drugs Authority (RFDA).
The drug manufactured by the Universal Corporation (UCL) Ltd in Kenya has been identified to have some incriminated tablets in some batches imported into the Rwandan market.
Fluconazole which is used to treat fungal and yeast infections including vaginal candidiasis, oropharyngeal candidiasis, candida esophagitis, and urinary tract infections among others has been recalled from all retail and facilities following an earlier letter in which the authority alerted the company of discolouration in some tablets.
In the announcement that was made on January 3 on social media platform X, the FDA noted that four batch numbers of the tablet which is supposed to be pink have begun turning white before the expected expiration dates on January 31 and August 31, 2025.
The batch numbers for the four are 5810315, 5810316, 5811390, and 5810022.
The FDA has since cautioned all importers, central medical stores, wholesale dealers, retailers, and all health facilities to return drugs with these batch numbers to suppliers.
The authority also mentioned that importers and suppliers of Fluconazole 200 mg tablets have 10 days from January 3 to report the affected quantities and the final stock in hand.
